Percutaneous Coronary Intervention in Patients With Gynecological Cancer: Machine Learning-Augmented Propensity Score Mortality and Cost Analysis for 383,760 Patients.

Journal: Frontiers in cardiovascular medicine
Published Date:

Abstract

BACKGROUND: Despite the growing number of patients with both coronary artery disease and gynecological cancer, there are no nationally representative studies of mortality and cost effectiveness for percutaneous coronary interventions (PCI) and this cancer type.

Authors

  • Nicole Thomason
    Division of Cardiology, The University of Texas Health Sciences Center at Houston, Houston, TX, United States.
  • Dominique J Monlezun
    Department of Cardiology, The University of Texas M.D. Anderson Cancer Center, Houston, TX, United States.
  • Awad Javaid
    Department of Internal Medicine, University of Nevada Las Vegas School of Medicine, Las Vegas, NV, United States.
  • Alexandru Filipescu
    Division of Cardiology, The University of Texas Health Sciences Center at Houston, Houston, TX, United States.
  • Efstratios Koutroumpakis
    Department of Cardiology, The University of Texas M.D. Anderson Cancer Center, Houston, TX, United States.
  • Fisayomi Shobayo
    Division of Cardiology, The University of Texas Health Sciences Center at Houston, Houston, TX, United States.
  • Peter Kim
    Department of Cardiology, The University of Texas M.D. Anderson Cancer Center, Houston, TX, United States.
  • Juan Lopez-Mattei
    Department of Cardiology, The University of Texas M.D. Anderson Cancer Center, Houston, TX, United States.
  • Mehmet Cilingiroglu
    Department of Internal Medicine, University of Nevada Las Vegas School of Medicine, Las Vegas, NV, United States.
  • Gloria Iliescu
    Department of Internal Medicine, The University of Texas Health Sciences Center at Houston, Houston, TX, United States.
  • Kostas Marmagkiolis
    Division of Cardiovascular Disease, University of Arkansas for Medical Sciences, Little Rock, AR, United States.
  • Pedro T Ramirez
    Department of GynOnc and Reproductive Medicine, The University of Texas Health Sciences Center at Houston, Houston, TX, United States.
  • Cezar Iliescu
    Department of Cardiology, The University of Texas M.D. Anderson Cancer Center, Houston, TX, United States.

Keywords

No keywords available for this article.